|
In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award
|
|
TCT Goes Tablet
|
|
New Study Demonstrates Potential Benefits of Shorter-Term Dual Antiplatelet Therapy in Patients Treated with a Second Generation Drug-Eluting Stent
|
|
New Study Finds Patients who are Event-Free Following PCI at One Year May Not Need Prolonged Dual Antiplatelet Therapy
|
|
Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiority of Newest Zotarolimus-Eluting Stent
|
|
Study Examines the Impact of Insulin Treatment Status in Diabetic Patients with Multivessel Coronary Artery Disease
|
|
"Hybrid Procedure" Combining Minimally Invasive Coronary Artery Bypass Surgery (CABG) with Percutaneous Coronary Intervention is Feasibile and Safe Compared with Tradtional CABG
|
|
New Study Evaluates Outcomes of Providing Access to Platelet Function Testing in a Clinical Setting
|
|
Genetic Profiling May Provide Clinical Benefit By Identifying Heart Attack Patients that are Resistant to Blood Thinners
|
|
Removing Blood Clots During PCI Does Not Improve Outcomes Compared to Standard Angioplasty in Patients with Non-ST-Elevation Myocardial Infarction
|
